The safety of the women who take part in our clinical trials is of paramount importance. To ensure their safety as well as the efficacy of the drugs that are being tested, we conduct placebo-controlled trials, frequently visit the sites where physicians and psychologists examine the physical and psychological wellbeing of the patients, and take every measure to ensure adherence to study protocols.
In addition, the safety and wellbeing of our trial subjects is ensured by compliance with the ICH GCP guidelines. All of our highly qualified staff are trained and frequently updated on the international ethical and scientific Good Clinical Practice quality standards of the International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use.
All of our studies are evaluated and approved by the competent authorities and local institutional review boards.